Von dem Buch Drug Receptor Interactions in Antimicrobial Chemotherapy Symposium, Vienna, September 4-6, 1974 haben wir 2 gleiche oder sehr ähnliche Ausgaben identifiziert!

Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:

Drug Receptor Interactions in Antimicrobial Chemotherapy Symposium, Vienna, September 4-6, 1974100%: Drews, J. (Herausgeber); Hahn, F. E. (Herausgeber): Drug Receptor Interactions in Antimicrobial Chemotherapy Symposium, Vienna, September 4-6, 1974 (ISBN: 9783709184073) in Englisch, Taschenbuch.
Nur diese Ausgabe anzeigen…
Drug Receptor Interactions in Antimicrobial Chemotherapy: Symposium, Vienna, September 4–6, 1974 (Topics in Infectious Diseases)65%: Herausgeber: J. Drews, Herausgeber: F.E. Hahn: Drug Receptor Interactions in Antimicrobial Chemotherapy: Symposium, Vienna, September 4–6, 1974 (Topics in Infectious Diseases) (ISBN: 9783709184059) Springer, Springer, Springer, in Englisch, auch als eBook.
Nur diese Ausgabe anzeigen…

Drug Receptor Interactions in Antimicrobial Chemotherapy Symposium, Vienna, September 4-6, 1974
12 Angebote vergleichen

Preise20142015201620202023
Schnitt 88,83 85,44 93,08 95,93 36,30
Nachfrage
Bester Preis: 16,99 (vom 20.05.2023)
1
9783709184073 - J. Drews: Drug Receptor Interactions in Antimicrobial Chemotherapy
Symbolbild
J. Drews

Drug Receptor Interactions in Antimicrobial Chemotherapy (2013)

Lieferung erfolgt aus/von: Deutschland DE PB NW

ISBN: 9783709184073 bzw. 370918407X, in Deutsch, Springer-Verlag KG Dez 2013, Taschenbuch, neu.

85,55 + Versand: 15,50 = 101,05
unverbindlich
Von Händler/Antiquariat, AHA-BUCH GmbH [51283250], Einbeck, Germany.
Neuware - The concept of chemotherapy as originated by Paul Ehrlich is based on the premise that antiparasitic drugs must have two properties: they must first bind to specific structures of the parasite which Ehrlich called chemoreceptors. Subsequent to their attachment to the chemoreceptor and by virtue of this binding they must possess the capacity to kill the parasite. Since the host which is to be cured of an invading parasite also contains a large number of chemoreceptors, that have the potential to bind toxic compounds, the task of the chemo therapist is to identify chemoreceptors of the parasite which are . not represented in the host and to design drugs which bind selectively to them~ In this context, Ehrlich called for 'the complete and exhaustive knowledge of all the different chemoreceptors of a certain parasite' as a 'sine qua non for success in chemotherapy'. Paradoxically and in spite of the fact that chemotherapy has become a very advanced and successful therapeutic discipline, few of its tri umphs have been achieved by following Ehrlich's original precepts. On the contrary, in the overwhelming majority of cases, effective drugs have been discovered without any knowledge of their chemoreceptors, and these drugs themselves have conversely been used as tools to study the nature of the chemoreceptors involved. In other words: chemother apy, notably antibacterial chemotherapy, has been successful without ever living up to the fundamental standards put forward by Paul Ehr lich. 314 pp. Englisch.
2
9783709184073 - J. Drews; F.E. Hahn: Drug Receptor Interactions in Antimicrobial Chemotherapy
J. Drews; F.E. Hahn

Drug Receptor Interactions in Antimicrobial Chemotherapy

Lieferung erfolgt aus/von: Deutschland ~EN PB NW

ISBN: 9783709184073 bzw. 370918407X, vermutlich in Englisch, Springer Shop, Taschenbuch, neu.

Lieferung aus: Deutschland, Lagernd.
The concept of chemotherapy as originated by Paul Ehrlich is based on the premise that antiparasitic drugs must have two properties: they must first bind to specific structures of the parasite which Ehrlich called chemoreceptors. Subsequent to their attachment to the chemoreceptor and by virtue of this binding they must possess the capacity to kill the parasite. Since the host which is to be cured of an invading parasite also contains a large number of chemoreceptors, that have the potential to bind toxic compounds, the task of the chemo­ therapist is to identify chemoreceptors of the parasite which are . not represented in the host and to design drugs which bind selectively to them~ In this context, Ehrlich called· for "the complete and exhaustive knowledge of all the different chemoreceptors of a certain parasite" as a "sine qua non for success in chemotherapy". Paradoxically and in spite of the fact that chemotherapy has become a very advanced and successful therapeutic discipline, few of its tri­ umphs have been achieved by following Ehrlich's original precepts. On the contrary, in the overwhelming majority of cases, effective drugs have been discovered without any knowledge of their chemoreceptors, and these drugs themselves have conversely been used as tools to study the nature of the chemoreceptors involved. In other words: chemother­ apy, notably antibacterial chemotherapy, has been successful without ever living up to the fundamental standards put forward by Paul Ehr­ lich. Soft cover.
3
9783709184059 - J. Drews; F.E. Hahn: Drug Receptor Interactions in Antimicrobial Chemotherapy
J. Drews; F.E. Hahn

Drug Receptor Interactions in Antimicrobial Chemotherapy

Lieferung erfolgt aus/von: Vereinigtes Königreich Großbritannien und Nordirland ~EN NW EB DL

ISBN: 9783709184059 bzw. 3709184053, vermutlich in Englisch, Springer Shop, neu, E-Book, elektronischer Download.

54,21 ($ 60,99)¹
unverbindlich
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Lagernd, zzgl. Versandkosten.
The concept of chemotherapy as originated by Paul Ehrlich is based on the premise that antiparasitic drugs must have two properties: they must first bind to specific structures of the parasite which Ehrlich called chemoreceptors. Subsequent to their attachment to the chemoreceptor and by virtue of this binding they must possess the capacity to kill the parasite. Since the host which is to be cured of an invading parasite also contains a large number of chemoreceptors, that have the potential to bind toxic compounds, the task of the chemo­ therapist is to identify chemoreceptors of the parasite which are . not represented in the host and to design drugs which bind selectively to them~ In this context, Ehrlich called· for "the complete and exhaustive knowledge of all the different chemoreceptors of a certain parasite" as a "sine qua non for success in chemotherapy". Paradoxically and in spite of the fact that chemotherapy has become a very advanced and successful therapeutic discipline, few of its tri­ umphs have been achieved by following Ehrlich's original precepts. On the contrary, in the overwhelming majority of cases, effective drugs have been discovered without any knowledge of their chemoreceptors, and these drugs themselves have conversely been used as tools to study the nature of the chemoreceptors involved. In other words: chemother­ apy, notably antibacterial chemotherapy, has been successful without ever living up to the fundamental standards put forward by Paul Ehr­ lich. eBook.
4
9783709184073 - J. Drews: Drug Receptor Interactions in Antimicrobial Chemotherapy
J. Drews

Drug Receptor Interactions in Antimicrobial Chemotherapy

Lieferung erfolgt aus/von: Deutschland DE PB NW

ISBN: 9783709184073 bzw. 370918407X, in Deutsch, Springer-Verlag KG, Taschenbuch, neu.

Lieferung aus: Deutschland, Versandkostenfrei.
Buchhandlung Kühn GmbH, [4368407].
Neuware - The concept of chemotherapy as originated by Paul Ehrlich is based on the premise that antiparasitic drugs must have two properties: they must first bind to specific structures of the parasite which Ehrlich called chemoreceptors. Subsequent to their attachment to the chemoreceptor and by virtue of this binding they must possess the capacity to kill the parasite. Since the host which is to be cured of an invading parasite also contains a large number of chemoreceptors, that have the potential to bind toxic compounds, the task of the chemo therapist is to identify chemoreceptors of the parasite which are . not represented in the host and to design drugs which bind selectively to them In this context, Ehrlich called for 'the complete and exhaustive knowledge of all the different chemoreceptors of a certain parasite' as a 'sine qua non for success in chemotherapy'. Paradoxically and in spite of the fact that chemotherapy has become a very advanced and successful therapeutic discipline, few of its tri umphs have been achieved by following Ehrlich's original precepts. On the contrary, in the overwhelming majority of cases, effective drugs have been discovered without any knowledge of their chemoreceptors, and these drugs themselves have conversely been used as tools to study the nature of the chemoreceptors involved. In other words: chemother apy, notably antibacterial chemotherapy, has been successful without ever living up to the fundamental standards put forward by Paul Ehr lich. Taschenbuch.
5
9783709184073 - J. Drews: Drug Receptor Interactions in Antimicrobial Chemotherapy
J. Drews

Drug Receptor Interactions in Antimicrobial Chemotherapy (2012)

Lieferung erfolgt aus/von: Deutschland DE PB NW

ISBN: 9783709184073 bzw. 370918407X, in Deutsch, Springer-Verlag KG, Taschenbuch, neu.

84,96 + Versand: 2,00 = 86,96
unverbindlich
buchversandmimpf2000, [3715720].
Neuware - The concept of chemotherapy as originated by Paul Ehrlich is based on the premise that antiparasitic drugs must have two properties: they must first bind to specific structures of the parasite which Ehrlich called chemoreceptors. Subsequent to their attachment to the chemoreceptor and by virtue of this binding they must possess the capacity to kill the parasite. Since the host which is to be cured of an invading parasite also contains a large number of chemoreceptors, that have the potential to bind toxic compounds, the task of the chemo therapist is to identify chemoreceptors of the parasite which are . not represented in the host and to design drugs which bind selectively to them In this context, Ehrlich called for 'the complete and exhaustive knowledge of all the different chemoreceptors of a certain parasite' as a 'sine qua non for success in chemotherapy'. Paradoxically and in spite of the fact that chemotherapy has become a very advanced and successful therapeutic discipline, few of its tri umphs have been achieved by following Ehrlich's original precepts. On the contrary, in the overwhelming majority of cases, effective drugs have been discovered without any knowledge of their chemoreceptors, and these drugs themselves have conversely been used as tools to study the nature of the chemoreceptors involved. In other words: chemother apy, notably antibacterial chemotherapy, has been successful without ever living up to the fundamental standards put forward by Paul Ehr lich. Taschenbuch.
6
9783709184073 - J. Drews: Drug Receptor Interactions in Antimicrobial Chemotherapy
J. Drews

Drug Receptor Interactions in Antimicrobial Chemotherapy (2012)

Lieferung erfolgt aus/von: Deutschland DE PB NW

ISBN: 9783709184073 bzw. 370918407X, in Deutsch, Springer-Verlag KG, Taschenbuch, neu.

Lieferung aus: Deutschland, Versandkostenfrei.
Carl Hübscher GmbH, [4514147].
Neuware - The concept of chemotherapy as originated by Paul Ehrlich is based on the premise that antiparasitic drugs must have two properties: they must first bind to specific structures of the parasite which Ehrlich called chemoreceptors. Subsequent to their attachment to the chemoreceptor and by virtue of this binding they must possess the capacity to kill the parasite. Since the host which is to be cured of an invading parasite also contains a large number of chemoreceptors, that have the potential to bind toxic compounds, the task of the chemo therapist is to identify chemoreceptors of the parasite which are . not represented in the host and to design drugs which bind selectively to them In this context, Ehrlich called for 'the complete and exhaustive knowledge of all the different chemoreceptors of a certain parasite' as a 'sine qua non for success in chemotherapy'. Paradoxically and in spite of the fact that chemotherapy has become a very advanced and successful therapeutic discipline, few of its tri umphs have been achieved by following Ehrlich's original precepts. On the contrary, in the overwhelming majority of cases, effective drugs have been discovered without any knowledge of their chemoreceptors, and these drugs themselves have conversely been used as tools to study the nature of the chemoreceptors involved. In other words: chemother apy, notably antibacterial chemotherapy, has been successful without ever living up to the fundamental standards put forward by Paul Ehr lich. Taschenbuch.
7
9783709184059 - Herausgeber: J. Drews, Herausgeber: F.E. Hahn: Drug Receptor Interactions in Antimicrobial Chemotherapy: Symposium, Vienna, September 4–6, 1974 (Topics in Infectious Diseases)
Herausgeber: J. Drews, Herausgeber: F.E. Hahn

Drug Receptor Interactions in Antimicrobial Chemotherapy: Symposium, Vienna, September 4–6, 1974 (Topics in Infectious Diseases) (2012)

Lieferung erfolgt aus/von: Deutschland EN NW EB DL

ISBN: 9783709184059 bzw. 3709184053, in Englisch, 314 Seiten, Springer, neu, E-Book, elektronischer Download.

Lieferung aus: Deutschland, E-Book zum Download, Versandkostenfrei.
The concept of chemotherapy as originated by Paul Ehrlich is based on the premise that antiparasitic drugs must have two properties: they must first bind to specific structures of the parasite which Ehrlich called chemoreceptors. Subsequent to their attachment to the chemoreceptor and by virtue of this binding they must possess the capacity to kill the parasite. Since the host which is to be cured of an invading parasite also contains a large number of chemoreceptors, that have the potential to bind toxic compounds, the task of the chemo­ therapist is to identify chemoreceptors of the parasite which are . not represented in the host and to design drugs which bind selectively to them~ In this context, Ehrlich called· for "the complete and exhaustive knowledge of all the different chemoreceptors of a certain parasite" as a "sine qua non for success in chemotherapy". Paradoxically and in spite of the fact that chemotherapy has become a very advanced and successful therapeutic discipline, few of its tri­ umphs have been achieved by following Ehrlich's original precepts. On the contrary, in the overwhelming majority of cases, effective drugs have been discovered without any knowledge of their chemoreceptors, and these drugs themselves have conversely been used as tools to study the nature of the chemoreceptors involved. In other words: chemother­ apy, notably antibacterial chemotherapy, has been successful without ever living up to the fundamental standards put forward by Paul Ehr­ lich. Kindle Edition, Format: Kindle eBook, Label: Springer, Springer, Produktgruppe: eBooks, Publiziert: 2012-12-06, Freigegeben: 2012-12-06, Studio: Springer.
8
9783709184059 - J. Drews: Drug Receptor Interactions in Antimicrobial Chemotherapy - Symposium, Vienna, September 4-6, 1974
J. Drews

Drug Receptor Interactions in Antimicrobial Chemotherapy - Symposium, Vienna, September 4-6, 1974 (1974)

Lieferung erfolgt aus/von: Deutschland ~EN NW EB DL

ISBN: 9783709184059 bzw. 3709184053, vermutlich in Englisch, Springer Vienna, neu, E-Book, elektronischer Download.

Lieferung aus: Deutschland, Versandkostenfrei.
Drug Receptor Interactions in Antimicrobial Chemotherapy: The concept of chemotherapy as originated by Paul Ehrlich is based on the premise that antiparasitic drugs must have two properties: they must first bind to specific structures of the parasite which Ehrlich called chemoreceptors. Subsequent to their attachment to the chemoreceptor and by virtue of this binding they must possess the capacity to kill the parasite. Since the host which is to be cured of an invading parasite also contains a large number of chemoreceptors, that have the potential to bind toxic compounds, the task of the chemo- therapist is to identify chemoreceptors of the parasite which are . not represented in the host and to design drugs which bind selectively to them~ In this context, Ehrlich called\* for "e the complete and exhaustive knowledge of all the different chemoreceptors of a certain parasite"e as a "e sine qua non for success in chemotherapy"e . Paradoxically and in spite of the fact that chemotherapy has become a very advanced and successful therapeutic discipline, few of its tri- umphs have been achieved by following Ehrlich`s original precepts. On the contrary, in the overwhelming majority of cases, effective drugs have been discovered without any knowledge of their chemoreceptors, and these drugs themselves have conversely been used as tools to study the nature of the chemoreceptors involved. In other words: chemother- apy, notably antibacterial chemotherapy, has been successful without ever living up to the fundamental standards put forward by Paul Ehr- lich. Englisch, Ebook.
9
9783709184073 - Drug Receptor Interactions in Antimicrobial Chemotherapy: Symposium, Vienna, September 4-6, 1974 J. Drews Editor

Drug Receptor Interactions in Antimicrobial Chemotherapy: Symposium, Vienna, September 4-6, 1974 J. Drews Editor (1974)

Lieferung erfolgt aus/von: Vereinigte Staaten von Amerika ~EN PB NW

ISBN: 9783709184073 bzw. 370918407X, vermutlich in Englisch, Springer Vienna, Taschenbuch, neu.

98,78 ($ 109,00)¹
unverbindlich
Lieferung aus: Vereinigte Staaten von Amerika, Lagernd, zzgl. Versandkosten.
The concept of chemotherapy as originated by Paul Ehrlich is based on the premise that antiparasitic drugs must have two properties: they must first bind to specific structures of the parasite which Ehrlich called chemoreceptors. Subsequent to their attachment to the chemoreceptor and by virtue of this binding they must possess the capacity to kill the parasite. Since the host which is to be cured of an invading parasite also contains a large number of chemoreceptors, that have the potential to bind toxic compounds, the task of the chemo­ therapist is to identify chemoreceptors of the parasite which are . not represented in the host and to design drugs which bind selectively to them~ In this context, Ehrlich called· for the complete and exhaustive knowledge of all the different chemoreceptors of a certain parasite as a sine qua non for success in chemotherapy. Paradoxically and in spite of the fact that chemotherapy has become a very advanced and successful therapeutic discipline, few of its tri­ umphs have been achieved by following Ehrlich's original precepts. On the contrary, in the overwhelming majority of cases, effective drugs have been discovered without any knowledge of their chemoreceptors, and these drugs themselves have conversely been used as tools to study the nature of the chemoreceptors involved. In other words: chemother­ apy, notably antibacterial chemotherapy, has been successful without ever living up to the fundamental standards put forward by Paul Ehr­ lich.
10
9783709184059 - F.E. Hahn, J. Drews: Drug Receptor Interactions in Antimicrobial Chemotherapy
F.E. Hahn, J. Drews

Drug Receptor Interactions in Antimicrobial Chemotherapy (2012)

Lieferung erfolgt aus/von: Vereinigtes Königreich Großbritannien und Nordirland EN NW EB DL

ISBN: 9783709184059 bzw. 3709184053, in Englisch, Springer, Springer, Springer, neu, E-Book, elektronischer Download.

75,21 (£ 65,03)¹
versandkostenfrei, unverbindlich
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, in-stock.
The concept of chemotherapy as originated by Paul Ehrlich is based on the premise that antiparasitic drugs must have two properties: they must first bind to specific structures of the parasite which Ehrlich called chemoreceptors. Subsequent to the.
Lade…